Article
Oncology
Ann Oluloro, Sarah M. Temkin, Jonathan Jackson, Elizabeth M. Swisher, Liz Sage, Kemi Doll
Summary: This study comprehensively assessed gynecologic cancer clinical trial protocols and found that they lack design elements that provide high value to Black individuals, such as lifestyle risk factors, ancestry, and remuneration. Inclusion of these valued items should be considered in efforts to improve diversity in clinical trial enrollment among Black individuals.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Oncology
Ewa Malchrowicz-Mosko, Piotr Nowaczyk, Janusz Wasiewicz, Tomasz Urbaniak, Wojciech Siejak, Mateusz Rozmiarek, Urszula Czerniak, Anna Demuth, Martinez Aguirre-Betolaza Aitor, Arkaitz Castaneda-Babarro
Summary: This study investigates the fear of movement in breast cancer patients undergoing surgical treatment and its relationship with socio-demographic variables, lifestyle before cancer diagnosis, stage and type of BC, and comorbidities. The findings show that breast cancer women experience high levels of kinesiophobia. A majority of the surveyed women are not aware of the WHO recommendations for physical activity. The level of kinesiophobia varies based on disease progression and is not affected by BC type or pre-diagnosis physical activity.
FRONTIERS IN ONCOLOGY
(2023)
Article
Oncology
Logan Corey, Julie Ruterbusch, Ron Shore, Martins Ayoola-Adeola, Michael Baracy, Alex Vezina, Ira Winer
Summary: The study evaluated the risk of developing a second primary cancer and associated survival times in women diagnosed with cancer in the United States between 1992 and 2017. It found that women with gynecologic cancer may develop non-gynecologic primary cancer, and women with non-gynecologic cancer may also develop gynecologic cancer. The risk and survival time of the second primary cancer depend on the order and site of the index and subsequent cancer.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Carlie A. Mell, Patricia Jewett, Deanna Teoh, Rachel Vogel, Susan A. Everson-Rose
Summary: This study aims to describe the fear of cancer recurrence among gynecologic cancer survivors and identify psychosocial factors that predict elevated fear. The findings reveal that fear of recurrence is prevalent among gynecologic cancer survivors. Higher levels of distress, hopelessness, anxiety, and surprisingly, post-traumatic growth are associated with greater fear. These results highlight the importance of addressing the psychosocial well-being of cancer survivors.
Article
Oncology
David Samuel, Deukwoo Kwon, Marilyn Huang, Wei Zhao, Molly Roy, Angel Tabuyo-Martin, John Siemon, Matthew P. Schlumbrecht, J. Matt Pearson, Abdulrahman K. Sinno
Summary: This study examines the factors associated with refusal of gynecologic cancer surgery and its impact on overall survival. The results show that patients who refuse surgery are more likely to be older, Black, uninsured, with Medicaid coverage, and have lower regional high school graduation rates. Refusal of surgery is also more common among patients treated at community hospitals. Patients who refuse surgery have lower median overall survival and this difference persists across different types of gynecologic cancer. The refusal of surgery has been increasing annually from 2008 to 2017.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Medicine, General & Internal
Kyeong A. So, Seung-Hyuk Shim, Sun Joo Lee, Tae Jin Kim
Summary: This study evaluated the characteristics and outcomes of surgical treatment in older patients with gynecologic cancers. The study included 131 patients aged 65 years and above who underwent surgery for gynecologic cancers. The results showed that older patients had good surgical outcomes and tolerable postoperative complications, indicating that surgical treatment can be safely offered to older patients with gynecologic cancers.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Oncology
Katharine M. Esselen, Rasha A. Baig, Annika Gompers, Hannah Stack-Dunnbier, Michele R. Hacker, Joanne W. Jang
Summary: This study evaluated financial toxicity (FT) in patients with gynecologic cancer treated with radiation and assessed the impact of the COVID-19 pandemic on patients' financial wellbeing. The study found that high FT was associated with worse quality of life, younger age, and type of insurance. The comparison of survey data also revealed lower financial toxicity in patients during the COVID-19 pandemic compared to the pre-pandemic period.
SUPPORTIVE CARE IN CANCER
(2023)
Article
Oncology
Yiting Stefanie Chen, Zhen Ni Zhou, Shannon M. Glynn, Melissa K. Frey, Onyinye D. Balogun, Margaux Kanis, Kevin Holcomb, Constantine Gorelick, Charlene Thomas, Paul J. Christos, Eloise Chapman-Davis
Summary: The study revealed that low-income patients with gynecologic cancer in NYC were significantly impacted by the COVID-19 pandemic, with factors like changes in employment status, early stage cancer, and lower annual income contributing to increased financial distress, cancer worry, and anxiety. Interventions focusing on improving access to timely oncology care for marginalized populations during the ongoing pandemic are recommended.
Article
Oncology
Grace B. Campbell, Sarah M. Belcher, Young Ji Lee, Madeleine Courtney-Brooks, Dana H. Bovbjerg, Zhadyra Bizhanova, Heidi S. Donovan
Summary: This study evaluated the feasibility and acceptability of daily symptom monitoring and functional assessments for gynecologic cancer patients, showing that intensive monitoring was feasible and well-received by patients, potentially providing a sense of symptom controllability. Participants rated the study participation positively.
Article
Oncology
Emily M. Ko, Justin E. Bekelman, Katherine Hicks-Courant, Colleen M. Brensinger, Genevieve P. Kanter
Summary: This study examined the impact of gynecologic oncology (GYO) versus medical oncology (MEDONC) care on survival, healthcare utilization, and spending outcomes in women with advanced gynecologic cancers. The findings showed that GYO care was associated with improved overall survival and similar spending in ovarian cancer patients. Uterine and cervical cancer patients had similar survival and lower or equal spending when treated by GYO compared to MEDONC.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Ayesha P. Ng, Yas Sanaiha, Arjun Verma, Cory Lee, Aaron Akhavan, Joshua G. Cohen, Peyman Benharash
Summary: This study evaluated the risk of financial toxicity among inpatients undergoing gynecologic cancer resections and found that uninsured patients were more likely to experience complications, longer hospital stays, and higher costs compared to insured patients. Approximately half of the uninsured patients were at risk of financial toxicity. Among insured patients, factors such as Black and Hispanic race, public insurance, and open operative approaches were associated with greater odds of financial toxicity.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Obstetrics & Gynecology
Ranjit Manchanda, Samuel Oxley, Sadaf Ghaem-Maghami, Sudha Sundar
Summary: The COVID-19 pandemic has led to a significant reconfiguration of gynecologic cancer services and care pathways globally, with adaptations to protect vulnerable patients, despite reduced resources and staffing. Remote working, routine COVID-testing, and priority levels for cancer treatments have enabled the safe delivery of care, although delays in surgeries and recruitment to cancer trials have been reported. Healthcare services must maintain capacity and flexibility during recovery to address the backlog of patients with altered treatments and evaluate long-term patient outcomes impacted by COVID-19.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
(2021)
Article
Oncology
Yiting Stefanie Chen, Zhen Ni Zhou, Shannon M. Glynn, Melissa K. Frey, Onyinye D. Balogun, Margaux Kanis, Kevin Holcomb, Constantine Gorelick, Charlene Thomas, Paul J. Christos, Eloise Chapman-Davis
Summary: During the peak of the NYC pandemic, COVID-19 had a significant impact on low-income patients with gynecologic cancer, leading to increased financial distress, anxiety, and cancer worry. Factors such as low income, early stage cancer, and delays in medical care were associated with higher levels of negative impacts. Actions aimed at improving access to timely oncology care are crucial for the ongoing pandemic.
Article
Oncology
Eran Ben-Arye, Naama Nijk, Ofer Lavie, Orit Gressel, Elad Schiff Md, Noah Samuels
Summary: This study examined the impact of a patient-tailored integrative oncology program on adherence to chemotherapy among patients with advanced gynecological cancer. The results showed that the patient-tailored program helped preserve adherence to chemotherapy, especially with taxane-based regimens.
SUPPORTIVE CARE IN CANCER
(2022)
Article
Oncology
Rachel A. Pozzar, Marilyn J. Hammer, Steven M. Paul, Bruce A. Cooper, Kord M. Kober, Yvette P. Conley, Jon D. Levine, Christine Miaskowski
Summary: Four distinct sleep disturbance profiles were identified among patients with gynecologic cancer, with over 80% reporting sleep disturbance persisting over two chemotherapy cycles. Patients in different classes showed differences in functional status, emotional symptoms, and fatigue levels, with those in the Very High class being younger and having a higher body mass index.
GYNECOLOGIC ONCOLOGY
(2021)
Article
Oncology
Christine J. McPherson, Alanna Devereaux
Summary: This study examines the dyadic effects of patient and caregiver attachment orientations on mutually supportive care in cancer treatment. It highlights the interdependence within the cancer caregiving relationship and emphasizes the importance of considering individual and relational ways of responding in providing support. Attachment theory provides a framework for understanding and therapeutic intervention.
